Regulatory Challenges and Opportunities for Gene Therapy

Time: 2:00 pm
day: Track B afternoon


  • What safety data are the regulators looking for from preclinical data to proceed
    into a clinical trial?
  • Key regulatory interactions with the FDA early on in development
  • Case study: IND filing of a second-generation gene therapy for Hemophilia A